189823-70-9

Basic information

• Product Name: ((1R,2S,3R,4R)-2,3-Bis-benzyloxy-4-benzyloxymethyl-cyclopentyl)-carbamic acid benzyl ester
• CAS NO: 189823-70-9
• Molecular Weight: 551.682
• Mol File: 189823-70-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: ((1R,2S,3R,4R)-2,3-Bis-benzyloxy-4-benzyloxymethyl-cyclopentyl)-carbamic acid benzyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: ((1R,2S,3R,4R)-2,3-Bis-benzyloxy-4-benzyloxymethyl-cyclopentyl)-carbamic acid benzyl ester(189823-70-9)
• EPA Substance Registry System: ((1R,2S,3R,4R)-2,3-Bis-benzyloxy-4-benzyloxymethyl-cyclopentyl)-carbamic acid benzyl ester(189823-70-9)

Safety Data

• Hazardous Substances Data: 189823-70-9(Hazardous Substances Data)

Upstream product

• 189823-68-5 (1R,2S,3R,4R)-2,3-Bis-benzyloxy-4-benzyloxymethyl-cyclopentanecarboxylic acid methyl ester 
• 100-51-6 benzyl alcohol 
• 189823-64-1 (1S,4R,5R,6S)-5,6-Bis-benzyloxy-bicyclo[2.2.1]hept-2-ene-2-carboxylic acid ethyl ester 
• 189823-66-3 (1R,2S,3R,4R)-2,3-Bis-benzyloxy-4-hydroxymethyl-cyclopentanecarboxylic acid methyl ester 
• 189823-60-7 (1S,2R,3R,4S,5R,6S)-3-Bromo-5,6-dihydroxy-bicyclo[2.2.1]heptane-2-carboxylic acid ethyl ester 
• 189823-62-9 (1S,4R,5R,6S)-5,6-Dihydroxy-bicyclo[2.2.1]hept-2-ene-2-carboxylic acid ethyl ester 
• 189823-58-3 (1R,2R,3R,4S)-3-Bromo-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid ethyl ester 
• 100-39-0 benzyl bromide 

Downstream Products

• 85026-59-1 (-)-(1R,2R,3S,4R)-4-amino-2,3-dihydroxy-1-(hydroxymethyl)cyclopentane 

Relevant articles and documents

Carbocyclic nucleoside analogs. 1. Concise enantioselective synthesis of functionalized cyclopentanes and formal total synthesis of aristeromycin

An enantioselective synthesis of functionalized cyclopentanes has been used to access carbocyclic nucleoside analogs. This pathway allows access to carbocyclic C- or carbocyclic N-nucleosides from a common intermediate, ester 16. Additionally, (1R,2R,3S,4R)-4-amino-2,3-dihydroxy-1-cyclopentanemethanol (18), an intermediate in the total synthesis of aristeromycin, has been prepared as a single enantiomer in eight isolated steps from cyclopentadiene. Progress toward the synthesis of novel carbocyclic C-nucleosides is also discussed.